Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation results of a prospective, randomized multicenter trial

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1707-1712

  Brozena, Susan C ^a,k   Johnson, Maryl R ^b   Ventura, Hector ^c   Hobbs, Robert ^d   Miller, Leslie ^e   Olivari, Maria Teresa ^f   Clemson, Barry ^g   Bourge, Robert ^h   Quigg, Rebecca ⁱ   Mills, Roger M ^j   Naftel, David ^h  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c OCHSNER MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e SAINT LOUIS UNIVERSITY   (United States)

^f UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^g St Francis Hospital   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF FLORIDA   (United States)

^k HAHNEMANN UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; DILTIAZEM; DIURETIC AGENT; LISINOPRIL; PREDNISONE;

ADULT; AGEUSIA; ALLERGIC REACTION; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HEADACHE; HEART TRANSPLANTATION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; TREMOR;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CYCLOSPORINE; DILTIAZEM; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LISINOPRIL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 8944258549     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00057-5     Document Type: Article

References (20)

1. Greenberg ML, Uretsky BF, Reddy PS, et al. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation 1985;71:487-94.
2. Olivari MT, Antolick A, Ring WS. Arterial hypertension in heart transplant recipients with triple drug immunosuppressive therapy. J Heart Lung Transplant 1989;8:34-9.
3. Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M. Factors influencing the development of hypertension after heart transplantation. J Heart Lung Transplant 1990;9:548-53.
4. Corcos T, Tamburino C, Leger P, et al. Early and late hemodynamic evaluation after cardiac transplantation: a study of 28 cases. J Am Coll Cardiol 1988;11:264-9.
5. Miller LW. Long-term complications of cardiac transplantation. Prog Cardiovasc Dis 1991;4:229-82.
6. Reeves RA, Shapiro AP, Thompson ME, Johnsen AM. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 1986;73: 401-8.
7. Starling RC, Cody RJ. Cardiac transplant hypertension. Am J Cardiol 1990;65:106-11.
8. Bellet M, Cabrol C, Sassano P, Leger P, Corvol P, Menard J. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. Am J Cardiol 1985;56:927-31.
9. Murali S, Uretsky BF, Reddy PS, Griffith BP, Hardesty RL, Trento A. Hemodynamic abnormalities following cardiac transplantation: relationship to hypertension and survival. Am Heart J 1989;118:334-41.
10. Ventura HO, Johnson MR, Grusk B, Pifarre R, Costanzo-Nordin MR. Cardiac adaptation to obesity and hypertension after heart transplantation. J Am Coll Cardiol 1992;19:55-9.
11. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-9.
12. Edwards BS, Hunt SA, Fowler MB, Valantine HA, Anderson LM, Lerman A. Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. Am J Cardiol 1991;67:782-4.
13. Miller LW, Pennington DG, McBride LR. Long-term effects of cyclosporine in cardiac transplantation. Transplant Proc 1990;22:15-20.
14. Keogh A, Macdonald P, Harvison A, Richens D, Mundy J, Spratt P. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question. J Heart Lung Transplant 1992;11:421-7.
15. Pritzker MR, Lake KD, Reutzel TJ, et al. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience. J Heart Lung Transplant 1992;11:415-20.
16. Singer DR, Markandu ND, Buckley MG, et al. Blood pressure and endocrine response to changes in dietary sodium intake in cardiac transplant recipients. Implications for the control of sodium balance. Circulation 1994;89:1153-9.
17. Kirk AJB, Omar I, Bateman DN, Dark JH. Cyclosporine-associated hypertension in cardiopulmonary transplantation. Transplantation 1989;48:428-30.
18. Elliott WJ, Murphy MB, Karp R. Long-term preservation of renal function in hypertensive heart transplant patients treated with enalapril and diuretic. J Heart Lung Transplant 1991;10:373-9.
19. Ventura HO, Milani RV, Lavie CJ, et al. Cyclosporine-induced hypertension. Efficacy of ω-3 fatty acids in patients after cardiac transplantation. Circulation 1993;88(Pt 2):281-5.
20. Van der Schaaf MR, Hene RJ, Floor M, Blankestijn PJ, Koomans HA. Hypertension after renal transplantation. Calcium channel or converting enzyme blockade? Hypertension 1995;25:77-81.